- Mirari Biosciences’ defunct platform combined Microwave-Accelerated Surface Chemistry (MASC) for microwave-driven solid-phase bio-reactions with “Peplica,” described as a “protein photocopier” that can, in theory, amplify down to a single protein molecule—raising questions about whether it performs true reverse translation or is simply advanced Edman degradation.  
- Archived company site: https://web.archive.org/web/20130614032249/http://miraribiosciences.com/  
- Discussion participants questioned the scientific credibility of Peplica, wondering if it is “just fancy marketing” or a genuine biomolecular reverse-translation system.  
- The firm ceased operations in mid-2014; its principal later joined a major pharmaceutical company and subsequently consulted for two other firms in related areas.  
- A side thread explored how many biotech startups spin off without formal academic credentials, implying concern over validation and reproducibility in the open-transhumanist ecosystem.